Study of JK07 in Patients With Chronic Heart Failure
A phase 2 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 282 participants.
Also called NCT06369298
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 282 participants
- Sponsor
- Salubris Biotherapeutics Inc
- Registry
-
NCT06369298
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Canada, China, Puerto Rico
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT06369298. Randomized; triple masking; primary purpose treatment. Start 2024-03-28 (actual); primary completion 2026-10-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Study of JK07 in Patients With Chronic Heart Failure
- Acronym
- RENEU-HF
- Intervention (Drug)
- JK07
- Intervention (Drug)
- Placebo
- Lead sponsor
- Salubris Biotherapeutics Inc
Record details
- Record id
cardio:ct-nct06369298- Content hash
459c9ea00f6a892cbac3a5b4148a8db39148c70fab137c6f918691fbd4b6c780